Does C72.50 require prior authorization?

No, C72.50 does not require prior authorization (high confidence). Covered without prior authorization.

`C72.50`, Malignant neoplasm of unspecified cranial nerve

ICD-10-CM

No Prior Auth Required

Covered without prior authorization (high confidence)

All documentation must be maintained in the patient's medical record and available to the contractor upon request.
Every page of the medical record must be legible and include appropriate patient identification (e.g., complete name, dates of service).
The record must include the physician or non-physician practitioner responsible for providing the care of the patient.
The patient's medical record should document the time spent in monitoring in correlation to the surgery performed.

Intraoperative neurophysiological testing is billable only when coverage criteria and medical necessity in related LCD L34623 are met.
Flow cytometry is covered to detect antigens used as therapeutic targets in neoplastic disease.
Flow cytometry is covered for diagnosis and classification of hematopoietic neoplasms.
Flow cytometry is covered to assess biologic parameters associated with prognosis in hematopoietic neoplasms.
Flow cytometry is covered to detect residual neoplastic cells following therapy (minimal residual disease detection).
Flow cytometry is covered to monitor lymphocyte populations in patients with HIV infection.

CGS-J15-L35906, Somatosensory Testing

J15

CGS-J15-L34037, Flow Cytometry

J15

CGS-J15-L38065, MolDX: Plasma-Based Genomic Profiling in Solid Tumors

J15

CGS-J15-L38822, MolDX: Minimal Residual Disease Testing for Cancer

J15

CGS-J15-L40225

Ask Backwork about documentation requirements, denial risks, or coverage in your state.